Search research articles
Contact Us
Filters
Showing results (21-30 of 224) with videos related to
Page
of 23
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
September 14, 2017
[Priorities of German Oncologists. Results of the "choosing wisely" survey of the German Society of Hematology and Medical Oncology (DGHO)]
Stefan W Krause, Michael Oldenburg, Michael Hallek, et al.
The American Journal of Surgical Pathology
|
June 27, 2003
B-cell monoclonality is associated with lymphoid follicles in gastritis
Thomas Wündisch, Andreas Neubauer, Manfred Stolte, et al.
Blood
|
November 22, 2011
Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib
Ashu Kumari, Cornelia Brendel, Andreas Hochhaus, et al.
Cytometry. Part B, Clinical Cytometry
|
May 6, 2021
Peripheral T-cell lymphoma immunophenotype in a patient with a history of Muromonab-CD3 therapy: A case report and a diagnostic dilemma
Joerg Hoffmann, Andreas Klameth, Martin Russwurm, et al.
Diagnostics (Basel, Switzerland)
|
August 26, 2022
The Low Expression of Fc-Gamma Receptor III (CD16) and High Expression of Fc-Gamma Receptor I (CD64) on Neutrophil Granulocytes Mark Severe COVID-19 Pneumonia
Joerg Hoffmann, Rojin Etati, Cornelia Brendel, et al.
Biochemical and Biophysical Research Communications
|
November 14, 2012
Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor
Philipp Nold, Cornelia Brendel, Andreas Neubauer, et al.
Leukemia & Lymphoma
|
May 10, 2007
Long-term treatment with rituximab is feasible in selected patients with B-CLL: response-adjusted low-dose maintenance treatment with rituximab in patients with relapsed B-CLL, who achieved a partial or minimal response to prior rituximab therapy
Stefanie Srock, Folke Schriever, Andreas Neubauer, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
March 18, 2017
Comparison of potassium and sodium binding in vivo and in agarose samples using TQTPPI pulse sequence
Victor D Schepkin, Andreas Neubauer, Armin M Nagel, et al.
Leukemia & Lymphoma
|
March 19, 2009
Clinical management of massive retroperitoneal hemorrhage after bone marrow biopsy
Albrecht Neesse, Marc Kalinowski, Eduard M Walthers, et al.
Immunotherapy
|
August 19, 2025
Cell and gene therapy in Germany: three decades of advanced technologies
Amit Sharma, Andreas Neubauer, Burghardt Wittig, et al.
Page
of 23
Search research articles
Search
Showing results (21-30 of 224) with videos related to
Sort By:
Page
of 23
Deutsche Medizinische Wochenschrift (1946)
|
September 14, 2017
[Priorities of German Oncologists. Results of the "choosing wisely" survey of the German Society of Hematology and Medical Oncology (DGHO)]
Stefan W Krause, Michael Oldenburg, Michael Hallek, et al.
The American Journal of Surgical Pathology
|
June 27, 2003
B-cell monoclonality is associated with lymphoid follicles in gastritis
Thomas Wündisch, Andreas Neubauer, Manfred Stolte, et al.
Blood
|
November 22, 2011
Low BCR-ABL expression levels in hematopoietic precursor cells enable persistence of chronic myeloid leukemia under imatinib
Ashu Kumari, Cornelia Brendel, Andreas Hochhaus, et al.
Cytometry. Part B, Clinical Cytometry
|
May 6, 2021
Peripheral T-cell lymphoma immunophenotype in a patient with a history of Muromonab-CD3 therapy: A case report and a diagnostic dilemma
Joerg Hoffmann, Andreas Klameth, Martin Russwurm, et al.
Diagnostics (Basel, Switzerland)
|
August 26, 2022
The Low Expression of Fc-Gamma Receptor III (CD16) and High Expression of Fc-Gamma Receptor I (CD64) on Neutrophil Granulocytes Mark Severe COVID-19 Pneumonia
Joerg Hoffmann, Rojin Etati, Cornelia Brendel, et al.
Biochemical and Biophysical Research Communications
|
November 14, 2012
Good manufacturing practice-compliant animal-free expansion of human bone marrow derived mesenchymal stroma cells in a closed hollow-fiber-based bioreactor
Philipp Nold, Cornelia Brendel, Andreas Neubauer, et al.
Leukemia & Lymphoma
|
May 10, 2007
Long-term treatment with rituximab is feasible in selected patients with B-CLL: response-adjusted low-dose maintenance treatment with rituximab in patients with relapsed B-CLL, who achieved a partial or minimal response to prior rituximab therapy
Stefanie Srock, Folke Schriever, Andreas Neubauer, et al.
Journal of Magnetic Resonance (San Diego, Calif. : 1997)
|
March 18, 2017
Comparison of potassium and sodium binding in vivo and in agarose samples using TQTPPI pulse sequence
Victor D Schepkin, Andreas Neubauer, Armin M Nagel, et al.
Leukemia & Lymphoma
|
March 19, 2009
Clinical management of massive retroperitoneal hemorrhage after bone marrow biopsy
Albrecht Neesse, Marc Kalinowski, Eduard M Walthers, et al.
Immunotherapy
|
August 19, 2025
Cell and gene therapy in Germany: three decades of advanced technologies
Amit Sharma, Andreas Neubauer, Burghardt Wittig, et al.
Page
of 23